Clinical Trials
10
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)
- Conditions
- Metastatic Prostate Cancer
- Interventions
- First Posted Date
- 2024-09-03
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Fundacion Oncosur
- Target Recruit Count
- 78
- Registration Number
- NCT06582628
- Locations
- 🇪🇸
Institut Català d'Oncologia (ICO), Badalona, Barcelona, Spain
🇪🇸Consorcio Corporación Sanitaria Parc Taulí, Sabadell, Barcelona, Spain
🇪🇸Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer
- Conditions
- Renal Cell Carcinoma Stage IVRenal Cell Carcinoma Stage IIIRenal Cell Carcinoma Metastatic
- Interventions
- First Posted Date
- 2024-04-22
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- Fundacion Oncosur
- Target Recruit Count
- 18
- Registration Number
- NCT06377722
- Locations
- 🇪🇸
Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
🇪🇸Institut Català d'Oncologia. Idibell, L'Hospitalet de Llobregat, Barcelona, Spain
🇪🇸Hospital Universitario de Valdecilla, Santander, Cantabria, Spain
Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)
- Conditions
- Prostate Cancer Metastatic
- Interventions
- First Posted Date
- 2022-10-03
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- Fundacion Oncosur
- Target Recruit Count
- 42
- Registration Number
- NCT05563558
- Locations
- 🇪🇸
Hospital Universitario 12 de Octubre, Madrid, Spain
Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer
- Conditions
- Triple Negative Breast Cancer
- Interventions
- Drug: Combination, Palbociclib + Binimetinib
- First Posted Date
- 2020-07-31
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Fundacion Oncosur
- Target Recruit Count
- 24
- Registration Number
- NCT04494958
- Locations
- 🇪🇸
Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain
🇪🇸Hospìtal Universitario de la Princesa, Madrid, Spain
🇪🇸Hospital Ramon y Cajal, Madrid, Spain
Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer.
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Fundacion Oncosur
- Target Recruit Count
- 184
- Registration Number
- NCT04253145
- Locations
- 🇪🇸
Hospital Virgen del Rocio, Sevilla, Andalucia, Spain
🇪🇸Hospital Virgen de la Victoria, Málaga, Andalucía, Spain
🇪🇸Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
- Prev
- 1
- 2
- Next